Nexavar and Ammonia abnormal - a phase IV clinical study of FDA data


Ammonia abnormal is found among people who take Nexavar, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Nexavar and have Ammonia abnormal. It is created by eHealthMe based on reports of 22,516 people who have side effects when taking Nexavar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

22,516 people reported to have side effects when taking Nexavar.
Among them, 7 people (0.03%) have Ammonia abnormal.

What is Nexavar?

Nexavar has active ingredients of sorafenib tosylate. It is often used in hepatocellular carcinoma. eHealthMe is studying from 22,624 Nexavar users for its effectiveness, alternative drugs and more.

What is Ammonia abnormal?

Ammonia abnormal is found to be associated with 303 drugs and 130 conditions by eHealthMe.

Number of Nexavar and Ammonia abnormal reports submitted per year:

Could Nexavar cause Ammonia abnormal?

Time on Nexavar when people have Ammonia abnormal *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Ammonia abnormal when taking Nexavar *:

  • female: 28.57 %
  • male: 71.43 %

Age of people who have Ammonia abnormal when taking Nexavar *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Nexavar *:

  1. Xifaxan: 1 person, 14.29%
  2. Vitamin D3: 1 person, 14.29%
  3. Vitamin D2: 1 person, 14.29%
  4. Vitamin D: 1 person, 14.29%
  5. Pantoprazole: 1 person, 14.29%
  6. Oxycodone: 1 person, 14.29%
  7. Norvasc: 1 person, 14.29%
  8. Lasix: 1 person, 14.29%
  9. Lantus: 1 person, 14.29%
  10. Humalog: 1 person, 14.29%

Common side effects people have besides Ammonia abnormal *:

  1. Hepatic Neoplasm Malignant (liver cancer): 2 people, 28.57%
  2. Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 2 people, 28.57%
  3. Ammonia Increased: 2 people, 28.57%
  4. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 28.57%
  5. C-Reactive Protein Increased: 2 people, 28.57%
  6. Liver Function Test Abnormal: 2 people, 28.57%
  7. Abdominal Pain: 2 people, 28.57%
  8. Pain In Extremity: 1 person, 14.29%
  9. Constipation: 1 person, 14.29%
  10. Fatigue (feeling of tiredness): 1 person, 14.29%

Common conditions people have *:

  1. Small Intestine Carcinoma (cancer tumour of small intestine): 1 person, 14.29%
  2. Hepatic Neoplasm Malignant (liver cancer): 1 person, 14.29%
  3. Hepatic Cancer Stage Iv: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Nexavar and have Ammonia abnormal?

Check whether Ammonia abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ammonia abnormal and when was it recovered:

Expand to all the drugs that have ingredients of sorafenib tosylate:

Alternative drugs to, pros and cons of Nexavar:

Common Nexavar side effects:

Browse all side effects of Nexavar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ammonia abnormal treatments and more:

COVID vaccines that are related to Ammonia abnormal:

All the drugs that are associated with Ammonia abnormal:

All the conditions that are associated with Ammonia abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on sorafenib tosylate (the active ingredients of Nexavar) and Nexavar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: